Clinical Trial Update: A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Advagraf (tacrolimus) for safety and efficacy in kidney and liver transplant recipients in India has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation, Liver Transplantation | Phase 4 | Status: COMPLETED